company background image
539680 logo

Ganga Pharmaceuticals BSE:539680 Stock Report

Last Price

₹18.62

Market Cap

₹90.1m

7D

0%

1Y

-28.0%

Updated

21 Dec, 2024

Data

Company Financials

Ganga Pharmaceuticals Limited

BSE:539680 Stock Report

Market Cap: ₹90.1m

539680 Stock Overview

Manufactures, markets, and distributes ayurvedic medicines in India. More details

539680 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Ganga Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ganga Pharmaceuticals
Historical stock prices
Current Share Price₹18.62
52 Week High₹28.49
52 Week Low₹15.00
Beta0.60
1 Month Change24.13%
3 Month Change-4.85%
1 Year Change-27.97%
3 Year Changen/a
5 Year Change106.89%
Change since IPO28.41%

Recent News & Updates

Recent updates

Shareholder Returns

539680IN Personal ProductsIN Market
7D0%-2.6%-4.2%
1Y-28.0%-4.9%19.1%

Return vs Industry: 539680 underperformed the Indian Personal Products industry which returned -4.9% over the past year.

Return vs Market: 539680 underperformed the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 539680's price volatile compared to industry and market?
539680 volatility
539680 Average Weekly Movementn/a
Personal Products Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 539680's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine 539680's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
197419Bharat Sharmawww.ayurvedganga.com

Ganga Pharmaceuticals Limited manufactures, markets, and distributes ayurvedic medicines in India. The company offers ayurvedic medicines for acidity and antidandruff, antioxidant, blood purifier and skin disorder, constipation, cough and cold, diarrhea, dental care, ear care, hair care, indigestion, kidney stone, liver disorder, sleep inducers, and weight management applications; and iron, female, and rejuvenation tonics, as well as products for hemorrhoids and piles, and joint pains. It also provides herbal cosmetic products.

Ganga Pharmaceuticals Limited Fundamentals Summary

How do Ganga Pharmaceuticals's earnings and revenue compare to its market cap?
539680 fundamental statistics
Market cap₹90.06m
Earnings (TTM)₹544.59k
Revenue (TTM)₹27.28m

165.4x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
539680 income statement (TTM)
Revenue₹27.28m
Cost of Revenue₹12.46m
Gross Profit₹14.81m
Other Expenses₹14.27m
Earnings₹544.59k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin54.31%
Net Profit Margin2.00%
Debt/Equity Ratio22.1%

How did 539680 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 12:18
End of Day Share Price 2024/12/13 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ganga Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution